Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Understanding the power of clonal heterogeneity in health and disease


Aaron Viny, MD, MS
Description

Immunohistochemistry (IHC) has been the gold standard to determine if a patient is in remission, but laboratories are transitioning into RT-PCR for fusions and flow cytometry for greater depth of response. However, clinicians are now moving away from algorithms to understand clonal architecture and mutation acquisition and trying their hand at newer technologies, such as single-cell DNA sequencing. Dr. Viny applies single-cell technology to examine clonal hematopoiesis and minimal residual disease (MRD) to better understand why some mutations are chemosensitive and others resistant to therapy.



VIEW


Scientific presentation
Introducing Europe to single-cell DNA sequencing
Gema Fuerte, MS
Mission Bio (2020)
Scientific presentation
Introducing Asia to single-cell DNA sequencing
Yue Wang, PhD
Mission Bio (2020)
Scientific presentation
How to detect DNA + Protein simultaneously in a single cell
Aik Ooi, PhD
Mission Bio (2020)
Scientific presentation
Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio
Kevin Corcoran
Aaron Llanso
Agilent & Mission Bio (2020)